Full Title
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Anupriya Singhal’s office at 646-888-4302.
Protocol
26-222
Phase
Phase III (phase 3)
Disease Status
Newly Diagnosed
Investigator
Co-Investigators
Locations
ClinicalTrials.gov ID
NCT07522073
ClinicalTrials.gov